ABCIXIMAB Side Effects

6831160-0 | Ruptured Cerebral Aneurysm
on Jun 29, 2010 Male patient from POLAND , 44 years of age, was diagnosed with stent placement, intracranial aneurysm and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: ruptured cerebral aneurysm. Abciximab dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), HEPARIN (5000 Units) (View Heparin Review and Heparin Label ), FRAXIPARINE (0.3-0.6 Ml Every 12 Hours) (View Fraxiparine Review and Fraxiparine Label ).

6748674-4 | Haemoglobin Decreased
Patient was taking Abciximab (View Usage). Patient had the following side effects: haemoglobin decreased on May 18, 2010 from FINLAND Additional patient health information: Female patient , 80 years of age, was diagnosed with percutaneous coronary intervention, atrial fibrillation (What is atrial fibrillation?) and. Abciximab dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6741245-5 | Vascular Pseudoaneurysm
Adverse event was reported on May 18, 2010 by a Female patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with percutaneous coronary intervention, atrial fibrillation (What is atrial fibrillation?) and. Location: FINLAND , 78 years of age, After Abciximab was administered, patient had the following side effects: vascular pseudoaneurysm. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6738990-4 | Angina Pectoris, Convulsion, Diarrhoea, Dizziness, Dyspnoea, Electrocardiogram Change, Fall, Gastric Haemorrhage, Gastrointestinal Arteriovenous Malformation
on May 24, 2010 Male patient from UNITED STATES , 82 years of age, was diagnosed with coronary arterial stent insertion and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, convulsion, diarrhoea, dizziness (What is dizziness?), dyspnoea, electrocardiogram change, fall (What is fall?), gastric haemorrhage, gastrointestinal arteriovenous malformation. Abciximab dosage: 0.125 Mcg Per Hour Iv. During the same period patient was treated with CLOPIDOGREL (75 Mg Every Day Po) (View Clopidogrel Review and Clopidogrel Label ).


6706304-1 | Acute Myocardial Infarction, Middle Insomnia, Platelet Count Decreased, Thrombosis In Device
on Apr 30, 2010 Female patient from UNITED STATES , 63 years of age, weighting 160.0 lb, was diagnosed with acute myocardial infarction and was treated with Abciximab (View Usage). Patient had the following side effects: acute myocardial infarction, middle insomnia, platelet count decreased, thrombosis in device. Abciximab dosage: 18.2 Mg Iv Bolus. Patient was hospitalized.

6696434-5 | Platelet Count Increased
Patient was taking Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: platelet count increased on Apr 22, 2010 from GERMANY Additional patient health information: Male patient , 48 years of age, was diagnosed with myocardial infarction and. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6692817-8 | Cardiac Tamponade
Adverse event was reported on Apr 19, 2010 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: GERMANY , 53 years of age, Patient experienced the following unwanted or unexpected effects: cardiac tamponade. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6667108-1 | Multi-organ Failure, Thrombocytopenia, Thrombosis
on Mar 25, 2010 Male patient from FRANCE , 52 years of age, was diagnosed with acute coronary syndrome and was treated with Abciximab (View Usage). Patient had the following side effects: multi-organ failure, thrombocytopenia, thrombosis. Abciximab dosage: Bolus. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ).

6663022-6 | Catheter Site Haemorrhage, Compartment Syndrome, Thrombocytopenia
on Mar 22, 2010 Female patient from KOREA, REPUBLIC OF , 56 years of age, was diagnosed with percutaneous coronary intervention and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: catheter site haemorrhage, compartment syndrome, thrombocytopenia. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (12 Units/kg/hr) (View Heparin Review and Heparin Label ).

6639646-9 | Catheter Site Haemorrhage, Compartment Syndrome, Thrombocytopenia
Patient was taking Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site haemorrhage, compartment syndrome, thrombocytopenia on Mar 11, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 56 years of age, was diagnosed with percutaneous coronary intervention and. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (3000 Unit Bolus) (View Heparin Review and Heparin Label ).

6545118-2 | Lung Infiltration, Pneumonitis, Pulmonary Toxicity
Adverse event was reported on Jan 13, 2010 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with angina unstable and. Location: UNITED KINGDOM , 77 years of age, Patient had the following side effects: lung infiltration, pneumonitis, pulmonary toxicity. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ). Patient was hospitalized and became disabled.

6541046-7 | Cerebrovascular Accident, Pituitary Haemorrhage, Tumour Haemorrhage
on Jan 05, 2010 Male patient from GERMANY , 59 years of age, was diagnosed with acute myocardial infarction and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: cerebrovascular accident, pituitary haemorrhage, tumour haemorrhage. Abciximab dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6426200-7 | Thrombocytopenia
on Nov 03, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with coronary arterial stent insertion and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Abciximab dosage: . Patient was hospitalized.

6424918-3 | Gastrointestinal Haemorrhage, Thrombocytopenia
Patient was taking Abciximab (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, thrombocytopenia on Nov 02, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with coronary arterial stent insertion and. Abciximab dosage: . Patient was hospitalized.

6420045-X | Brain Oedema, Intraventricular Haemorrhage, Subarachnoid Haemorrhage, Thrombocytopenia
Adverse event was reported on Oct 22, 2009 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with embolism and. Location: GERMANY , 50 years of age, After Abciximab was administered, patient had the following side effects: brain oedema, intraventricular haemorrhage, subarachnoid haemorrhage, thrombocytopenia. During the same period patient was treated with HEPARIN (2,500 To 3,000 Units Per Hour) (View Heparin Review and Heparin Label ).

6420044-8 | Intraventricular Haemorrhage, Subarachnoid Haemorrhage, Thrombocytopenia
on Oct 22, 2009 Male patient from GERMANY , 57 years of age, was diagnosed with embolism and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: intraventricular haemorrhage, subarachnoid haemorrhage, thrombocytopenia. Abciximab dosage: . During the same period patient was treated with HEPARIN (2500 To 3000 Units/hour) (View Heparin Review and Heparin Label ).

6420043-6 | Subarachnoid Haemorrhage, Thrombocytopenia
on Oct 22, 2009 Female patient from GERMANY , 85 years of age, was diagnosed with embolism and was treated with Abciximab (View Usage). Patient had the following side effects: subarachnoid haemorrhage, thrombocytopenia. Abciximab dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6406735-3 | Cardiac Tamponade
Patient was taking Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: cardiac tamponade on Oct 09, 2009 from GERMANY Additional patient health information: Male patient , 53 years of age, was diagnosed with myocardial infarction and. Abciximab dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6379683-5 | Epistaxis, Platelet Aggregation, Thrombocytopenia
Adverse event was reported on Sep 24, 2009 by a Male patient taking Abciximab (View Usage) (Dosage: 26 Mg Once Iv) . Location: UNITED STATES , 63 years of age, weighting 228.0 lb, Patient experienced the following unwanted or unexpected effects: epistaxis, platelet aggregation, thrombocytopenia. During the same period patient was treated with HEPARIN (5000 Units Other Sq) (View Heparin Review and Heparin Label ).

6213134-6 | Thrombocytopenia
on Jun 01, 2009 Male patient from UNITED STATES , 58 years of age, was diagnosed with carotid artery stent insertion and was treated with Abciximab (View Usage). Patient had the following side effects: thrombocytopenia. Abciximab dosage: 2 Mg Other Iv. Patient was hospitalized.

6177806-4 | Thrombocytopenia
on May 01, 2009 Male patient from UNITED STATES , 56 years of age, was diagnosed with cardiovascular disorder, surgery (What is surgery?) and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: thrombocytopenia. Abciximab dosage: . Patient was hospitalized.

6139994-5 | Gingival Bleeding, Thrombocytopenia
Patient was taking Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: gingival bleeding, thrombocytopenia on Mar 26, 2009 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 65 years of age, was diagnosed with percutaneous coronary intervention, myocardial infarction and. Abciximab dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5978695-0 | Haemorrhage Intracranial
Adverse event was reported on Dec 02, 2008 by a Female patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with intracranial aneurysm and. Location: UNITED KINGDOM , 59 years of age, Patient had the following side effects: haemorrhage intracranial. During the same period patient was treated with HEPARIN (Catheters Were Continuously Flushed With 5 Iu/mlml) (View Heparin Review and Heparin Label ).

5978694-9 | Haemorrhage Intracranial
on Dec 02, 2008 Female patient from UNITED KINGDOM , 48 years of age, was diagnosed with intracranial aneurysm and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: haemorrhage intracranial. Abciximab dosage: . During the same period patient was treated with HEPARIN (Catheters Were Continuously Flushed With 5 Iu/mlml) (View Heparin Review and Heparin Label ).

5929464-9 | Cardiac Tamponade, Pericardial Haemorrhage
on Oct 21, 2008 Male patient from GREECE , 61 years of age, was diagnosed with coronary artery thrombosis, myocardial infarction, angioplasty (What is angioplasty?) and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac tamponade, pericardial haemorrhage. Abciximab dosage: . During the same period patient was treated with RETEPLASE (View Reteplase Review and Reteplase Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5875946-8 | Pneumonitis
Patient was taking Abciximab (View Usage). Patient had the following side effects: pneumonitis on Aug 29, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 77 years of age, was diagnosed with angina unstable and. Abciximab dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

5737844-X | Platelet Count Increased
Adverse event was reported on May 08, 2008 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: GERMANY , 48 years of age, After Abciximab was administered, patient had the following side effects: platelet count increased. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5728675-5 | Platelet Count Increased
on Apr 29, 2008 Male patient from GERMANY , 48 years of age, was diagnosed with myocardial infarction and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count increased. Abciximab dosage: .

5688499-4 | Brain Oedema, Intraventricular Haemorrhage, Subarachnoid Haemorrhage, Thrombocytopenia
on Mar 21, 2008 Male patient from KOREA, REPUBLIC OF , 50 years of age, was diagnosed with embolism and was treated with Abciximab (View Usage). Patient had the following side effects: brain oedema, intraventricular haemorrhage, subarachnoid haemorrhage, thrombocytopenia. Abciximab dosage: . During the same period patient was treated with HEPARIN (2,500 To 3,000 Units Per Hour) (View Heparin Review and Heparin Label ).

5680356-2 | Subarachnoid Haemorrhage, Thrombocytopenia
Patient was taking Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: subarachnoid haemorrhage, thrombocytopenia on Mar 21, 2008 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 85 years of age, was diagnosed with embolism and. Abciximab dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5680355-0 | Intraventricular Haemorrhage, Subarachnoid Haemorrhage, Thrombocytopenia
Adverse event was reported on Mar 21, 2008 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with embolism and. Location: KOREA, REPUBLIC OF , 57 years of age, Patient experienced the following unwanted or unexpected effects: intraventricular haemorrhage, subarachnoid haemorrhage, thrombocytopenia. During the same period patient was treated with HEPARIN (2500 To 3000 Units/hour) (View Heparin Review and Heparin Label ).

5677426-1 | Acute Myocardial Infarction, Akinesia, Epigastric Discomfort, Gastroenteritis Radiation, Haemoglobin Decreased, Hypotension, In-stent Coronary Artery Restenosis, Prothrombin Time Prolonged, Rectal Haemorrhage
on Mar 18, 2008 Male patient from AUSTRALIA , 64 years of age, was diagnosed with percutaneous coronary intervention and was treated with Abciximab (View Usage). Patient had the following side effects: acute myocardial infarction, akinesia, epigastric discomfort, gastroenteritis radiation, haemoglobin decreased, hypotension, in-stent coronary artery restenosis, prothrombin time prolonged, rectal haemorrhage. Abciximab dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), INOTROPES (View Inotropes Review and Inotropes Label ), FLUIDS (View Fluids Review and Fluids Label ), HEAPRIN (View Heaprin Review and Heaprin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5535254-1 | Anaemia, Contusion, Epistaxis, Thrombocytopenia
on Nov 27, 2007 Male patient from UNITED KINGDOM , 77 years of age, weighting 187.4 lb, was diagnosed with surgery (What is surgery?), blood pressure increased, atrial fibrillation (What is atrial fibrillation?) and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: anaemia, contusion, epistaxis, thrombocytopenia. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

5418180-8 | Gastrointestinal Haemorrhage
Patient was taking Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage on Aug 03, 2007 from POLAND Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with acute myocardial infarction, bradycardia, ventricular fibrillation, prophylaxis, analgesia and. Abciximab dosage: . During the same period patient was treated with RETAVASE (View Retavase Review and Retavase Label ), ATROPINE (View Atropine Review and Atropine Label ), CORDARONE (View Cordarone Review and Cordarone Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MORPHINE (View Morphine Review and Morphine Label ).

5418145-6 | Arterial Injury, Pericardial Haemorrhage
Adverse event was reported on Aug 03, 2007 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with myocardial infarction, cardiac disorder, blood cholesterol and. Location: UNITED KINGDOM , weighting 172.0 lb, Patient had the following side effects: arterial injury, pericardial haemorrhage. During the same period patient was treated with RETAVASE (View Retavase Review and Retavase Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ATROVASTATIN (View Atrovastatin Review and Atrovastatin Label ).

5414833-6 | Gastrointestinal Haemorrhage, Mallory-weiss Syndrome
on Aug 03, 2007 Male patient from BELGIUM , weighting 141.1 lb, was diagnosed with acute myocardial infarction, hypercholesterolaemia, stent placement and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: gastrointestinal haemorrhage, mallory-weiss syndrome. Abciximab dosage: . During the same period patient was treated with RETAVASE (View Retavase Review and Retavase Label ), ZOCOR (View Zocor Review and Zocor Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5414819-1 | Gastric Haemorrhage, Pneumonia Aspiration, Renal Failure
on Aug 03, 2007 Male patient from BELGIUM , weighting 194.0 lb, was diagnosed with acute myocardial infarction and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: gastric haemorrhage, pneumonia aspiration, renal failure. Abciximab dosage: . During the same period patient was treated with RETAVASE (View Retavase Review and Retavase Label ).

5414818-X | Cardiogenic Shock, Haemorrhagic Stroke
Patient was taking Abciximab (View Usage). Patient had the following side effects: cardiogenic shock, haemorrhagic stroke on Aug 03, 2007 from BULGARIA Additional patient health information: Male patient , weighting 147.7 lb, was diagnosed with acute myocardial infarction, prophylaxis against gastrointestinal ulcer and. Abciximab dosage: . During the same period patient was treated with RETAVASE (View Retavase Review and Retavase Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5414817-8 | Gastrointestinal Haemorrhage, Myocardial Rupture, Pericardial Haemorrhage
Adverse event was reported on Aug 03, 2007 by a Female patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: DENMARK , weighting 145.5 lb, After Abciximab was administered, patient had the following side effects: gastrointestinal haemorrhage, myocardial rupture, pericardial haemorrhage. During the same period patient was treated with MAGNYL (View Magnyl Review and Magnyl Label ), PLAVIX (View Plavix Review and Plavix Label ), PREDNISON (View Prednison Review and Prednison Label ).

5414806-3 | Femoral Artery Aneurysm
on Aug 03, 2007 Male patient from FRANCE , weighting 211.6 lb, was diagnosed with myocardial infarction, acute myocardial infarction and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: femoral artery aneurysm. Abciximab dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LOVENOX (View Lovenox Review and Lovenox Label ), TRIATEC (View Triatec Review and Triatec Label ), ELISOR (View Elisor Review and Elisor Label ).

5413498-7 | Haemorrhage Intracranial
on Aug 03, 2007 Male patient from AUSTRIA , weighting 176.4 lb, was diagnosed with acute myocardial infarction, hypertension and was treated with Abciximab (View Usage). Patient had the following side effects: haemorrhage intracranial. Abciximab dosage: . During the same period patient was treated with RETAVASE (View Retavase Review and Retavase Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

5411839-8 | Cardiogenic Shock, Cerebrovascular Disorder
Patient was taking Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: cardiogenic shock, cerebrovascular disorder on Aug 03, 2007 from UNITED KINGDOM Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with myocardial infarction, acute myocardial infarction, hypotension, myocardial ischaemia and. Abciximab dosage: . During the same period patient was treated with DOBUTAMINE HCL (Dose Variable) (View Dobutamine Hcl Review and Dobutamine Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

5411838-6 | Cardiac Tamponade, Chest Pain, Ventricular Fibrillation
Adverse event was reported on Aug 03, 2007 by a Male patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction, cardiac failure and. Location: FRANCE , weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: cardiac tamponade, chest pain (What is chest pain?), ventricular fibrillation. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), PLAVIX (View Plavix Review and Plavix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), TRIATEC (View Triatec Review and Triatec Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5397459-2 | Thrombocytopenia
on Jul 23, 2007 Male patient from UNITED STATES , 62 years of age, was treated with Abciximab (View Usage). Patient had the following side effects: thrombocytopenia. Abciximab dosage: . Patient was hospitalized.

5375916-2 | Cerebral Haematoma, Loss Of Consciousness
on Aug 06, 2003 Female patient from DENMARK , weighting 99.21 lb, was diagnosed with myocardial infarction and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: cerebral haematoma, loss of consciousness. Abciximab dosage: . During the same period patient was treated with RETEPLASE (View Reteplase Review and Reteplase Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5275299-2 | Gastrointestinal Haemorrhage, Haematoma, Renal Failure Acute, Retroperitoneal Haemorrhage
Patient was taking Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, haematoma, renal failure acute, retroperitoneal haemorrhage on Mar 19, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 67 years of age, was diagnosed with thrombolysis and. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), RAPILYSIN (View Rapilysin Review and Rapilysin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized and became disabled.

5270786-5 | Nodal Arrhythmia, Sinus Arrest, Supraventricular Extrasystoles, Thrombocytopenia
Adverse event was reported on Aug 25, 2005 by a Female patient taking Abciximab (View Usage) (Dosage: ) was diagnosed with coronary angioplasty, diabetes mellitus, cardiovascular event prophylaxis, hypertension, renal failure, nausea (What is nausea?) and. Location: CANADA , weighting 110.0 lb, Patient had the following side effects: nodal arrhythmia, sinus arrest, supraventricular extrasystoles, thrombocytopenia. During the same period patient was treated with NOVOLIN 50/50 (View Novolin 50/50 Review and Novolin 50/50 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VASOTEC (View Vasotec Review and Vasotec Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), HEPARIN (View Heparin Review and Heparin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), GRAVOL TAB (View Gravol Tab Review and Gravol Tab Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ).

5264681-5 | Anaemia, Contusion, Epistaxis, Thrombocytopenia
on Mar 08, 2007 Male patient from UNITED KINGDOM , 77 years of age, weighting 187.4 lb, was diagnosed with surgery (What is surgery?), blood pressure increased, atrial fibrillation (What is atrial fibrillation?) and was treated with Abciximab (View Usage). After Abciximab was administered, patient had the following side effects: anaemia, contusion, epistaxis, thrombocytopenia. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

5264680-3 | Gastrointestinal Haemorrhage, Haematoma, Renal Failure Acute, Retroperitoneal Haemorrhage
on Mar 08, 2007 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with thrombolysis and was treated with Abciximab (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, haematoma, renal failure acute, retroperitoneal haemorrhage. Abciximab dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), RAPILYSIN (View Rapilysin Review and Rapilysin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized and became disabled.

5259606-2 | Pulmonary Alveolar Haemorrhage, Respiratory Failure
Patient was taking Abciximab (View Usage). Patient had the following side effects: pulmonary alveolar haemorrhage, respiratory failure on Mar 08, 2007 from ITALY Additional patient health information: Male patient , 66 years of age, was diagnosed with acute myocardial infarction and. Abciximab dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.